WASHINGTON, Sept. 6, 2016 -- Thanks to a new, cheap and accurate DNA-editing technique called CRISPR-Cas9, targeted genetic modification in humans is no longer just the realm of science fiction. Both the British and U.S. governments recently gave scientists the thumbs-up to edit DNA in human embryos and adults using CRISPR. So does this mean that we can trim out genetic diseases or mutations? Or maybe even add in abilities like infrared vision, possibly creating a designer-baby dystopia? In the latest Reactions episode, we explain how CRISPR works, how it is being used today and what the future might bring for this landmark technology: https://youtu.be/5gQGWJraptU.
Subscribe to the series at http://bit.ly/ACSReactions, and follow us on Twitter @ACSreactions to be the first to see our latest videos.
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 158,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
Thanks to a new, cheap and accurate DNA-editing technique called CRISPR-Cas9, targeted genetic modification in humans is no longer just the realm of science fiction. Both the British and US governments recently gave scientists the thumbs-up to edit DNA in human embryos and adults using CRISPR. In the latest Reactions episode, we explain how CRISPR works, how it is being used today and what the future might bring for this landmark technology: https://youtu.be/5gQGWJraptU. Credit: The American Chemical Society
To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org">newsroom@acs.org.
source: American Chemical Society